According to Biotest 's latest financial reports the company's current earnings are NZ$0.77 Billion. In 2023 the company made an earning of NZ$0.26 Billion, an increase over its 2022 earnings that were of -NZ$19.46 Million. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2024 (TTM) | NZ$0.15 B | -39.7% |
2023 | NZ$0.26 B | -1455.72% |
2022 | -NZ$19.46 Million | -79.44% |
2021 | -NZ$94.64 Million | 359.41% |
2020 | -NZ$20.6 Million | -213.86% |
2019 | NZ$18.09 M | -20.6% |
2018 | NZ$22.78 M | -135.69% |
2017 | -NZ$63.85 Million | -139.86% |
2016 | NZ$0.16 B | -227.25% |
2015 | -NZ$0.13 Billion | -199.09% |
2014 | NZ$0.12 B | 5.24% |
2013 | NZ$0.12 B | 29.54% |
2012 | NZ$93.17 M | -35.34% |
2011 | NZ$0.14 B | 28.46% |
2010 | NZ$0.11 B | -31.44% |
2009 | NZ$0.16 B |